Format

Send to

Choose Destination
See comment in PubMed Commons below
J Am Chem Soc. 2003 Nov 5;125(44):13387-91.

Reversible "irreversible" inhibition of chymotrypsin using nanoparticle receptors.

Author information

1
Molecular and Cellular Biology Program, University of Massachusetts, Amherst, Massachusetts 01003, USA.

Abstract

Anionically functionalized amphiphilic nanoparticles efficiently inhibit chymotrypsin through electrostatic binding followed by protein denaturation. We demonstrate the ability to disrupt this "irreversible" inhibition of chymotrypsin through modification of the nanoparticle surface using cationic surfactants. Up to 50% of original chymotrypsin activity is rescued upon long-chain surfactant addition. Dynamic light-scattering studies demonstrate that chymotrypsin is released from the nanoparticle surface. The conformation of the rescued chymotrypsin was characterized by fluorescence and fluorescence anisotropy, indicating that chymotrypsin regains a high degree of native structure upon surfactant addition.

PMID:
14583034
DOI:
10.1021/ja0352505
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for American Chemical Society
    Loading ...
    Support Center